Association of I/D angiotensin-converting enzyme genotype with erythropoietin stimulation in kidney failure

Association of I/D angiotensin-converting enzyme genotype with erythropoietin stimulation in kidney failure

Angiotensin-converting enzyme (ACE)-gene polymorphism is a possible predisposing factor of erythropoietin response under hypoxic conditions. However, it is not completely clear whether the ACE insertion/deletion (I/D) genotype has an impact on anemia in patients with permanent kidney failur...

Full description

Bibliographic Details
Main Authors:	Savin Marina, Hadzibulic Edvin, Damnjanović Tatjana, Santric Veljko, Stankovic Sanja
Format:	Article
Language:	English
Published:	University of Belgrade, University of Novi Sad 2017-01-01
Series:	Archives of Biological Sciences
Subjects:	hemodialysis hemoglobin oral iron IV iron epoetin beta ACE I/D genotype
Online Access:	http://www.doiserbia.nb.rs/img/doi/0354-4664/2017/0354-46641600051S.pdf

Similar Items

Evaluating the effectiveness of IV iron dosing for anemia management in common clinical practice: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)
by: Bruce M. Robinson, et al.
Published: (2017-11-01)

Comparison of methodologies to define hemodialysis patients hyporesponsive to epoetin and impact on counts and characteristics
by: Gilbertson David T, et al.
Published: (2013-02-01)

ACE gene polymorphism and its association with serum erythropoietin and hemoglobin &lrm;in Iraqi hemodialysis patients
by: Al-Radeef ‎MY, et al.
Published: (2019-07-01)

Own experience of treatment by epoetin-α (Eralfon®) of chemotherapy induced anemia
by: S A Bolshakova, et al.
Published: (2017-01-01)

In Vitro and In Vivo Evaluations of Mesoporous Iron Particles for Iron Bioavailability
by: Jung-Feng Lin, et al.
Published: (2019-10-01)

Angiotensin-converting enzyme gene polymorphism in autosomal dominant polycystic kidney disease
by: Sanjeev Nair, et al.
Published: (2014-01-01)

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
by: Darcy Adin, et al.
Published: (2020-03-01)

Recombinant human erythropoietin in sports: a review
by: Rafael Maia de Almeida Bento, et al.
Published: (2003-06-01)

Effect of erythropoietin in treatment of renal anemia in a sample of Iraqi patient
by: Ali J. Hashim Al Saedi, et al.
Published: (2021-01-01)

Achievement of renal anemia KDIGO targets by two different clinical strategies – a European hemodialysis multicenter analysis
by: Maciej Drozdz, et al.
Published: (2019-01-01)

CORRECTING OF ANEMIA USING IRON SUCROSE IN PATIENTS WITH CHRONIC KIDNEYDISEASE STAGE VD ON HEMODIALYSIS
by: I. Dudar, et al.
Published: (2014-08-01)

Impact of hepcidin, interleukin 6, and other inflammatory markers with respect to erythropoietin on anemia in chronic hemodialysis patients
by: Ihab A. Ibrahim, et al.
Published: (2014-01-01)

INFLUENCE OF EPOETIN ALFA ON LEVEL OF PROINFLAMMATORY AND ANTIINFLAMMATORY CYTOKINE OF PATIENTS IN MAINTENCE HEMODIALYSIS
by: I. Dudar, et al.
Published: (2014-03-01)

Haematological Indicators of Response to Erythropoietin Therapy in Chronic Renal Failure Patients on Haemodialysis: Impact of Angiotensin-Converting Enzyme rs4343 Gene Polymorphism
by: Hamdan Almaeen A, et al.
Published: (2021-08-01)

A novel outpatient desensitization protocol for recombinant human erythropoietin allergy in a pediatric patient
by: Jaime S. Rosa, et al.
Published: (2018-03-01)

Biosimilar Retacrit® (epoetin zeta) in the treatment of chemotherapy-induced symptomatic anemia in hematology and oncology in Germany (ORHEO) – non-interventional study
by: Losem C, et al.
Published: (2017-02-01)

Gender differences in dose of erythropoietin to maintain hemoglobin target in hemodialysis patients
by: J A Coronado Daza, et al.
Published: (2019-01-01)

HUBUNGAN ASUPAN ZAT BESI DAN INHIBITORNYA SEBAGAI PREDIKTOR KADAR HEMOGLOBIN IBU HAMIL DI KABUPATEN MUARA ENIM
by: Jhon Riswanda
Published: (2017-08-01)

The Determinants of Hemoglobin Variability in Hemodialysis Patients
by: Tomanoski Vasilije, et al.
Published: (2016-12-01)

Efficiency of Converting Iron into Hemoglobin as an Assay for Evaluating Iron Bioavailability
by: Whittaker, Paul
Published: (1983)

Randomized double-blind clinical trial of a new human epoetin versus a commercially available formula for anemia control in patients on hemodialysis
by: Paulo D. Picon, et al.
Published: (2014-08-01)

An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients
by: Besarab Anatole, et al.
Published: (2012-08-01)

Lower serum prohepcidin levels associated with lower iron and erythropoietin requirements in hemodialysis patients with chronic hepatitis C
by: Caliskan Yasar, et al.
Published: (2012-07-01)

The hemoglobin concentration and total iron content of albino rats at birth as influenced by the store of iron in the mother
by: Ridder, Clara Ann, 1912-
Published: (1938)

Some physiological aspects of iron transport - studies on the fortification of sugar with iron
by: Disler, Peter, Barry
Published: (2018)

THE ROLE OF ERYTHROPOIETIN IN TREATMENT OF ANEMIA IN CANCER PATIENTS
by: P. G. Berezin, et al.
Published: (2017-06-01)

Novel dipeptidyl peptidase‐IV and angiotensin‐I‐converting enzyme inhibitory peptides released from quinoa protein by in silico proteolysis
by: Huimin Guo, et al.
Published: (2020-03-01)

Iron-Containing Oral Contraceptives and Their Effect on Hemoglobin and Biomarkers of Iron Status: A Narrative Review
by: Jordie A. J. Fischer, et al.
Published: (2021-07-01)

Angiotensin-Converting Enzyme Genotype and Acute Pancreatitis in Turkey
by: Kasap E, et al.
Published: (2009-01-01)

Prolonged response to recombinant human erythropoietin treatment in patients with myelodysplastic syndrome at a single referral centre in Brazil
by: Anna Thawanny Gadelha Moura, et al.

Iron replacement therapy in heart failure: a literature review
by: Hassan Ismahel, et al.
Published: (2021-09-01)

Determination of iron sucrose (Venofer) or iron dextran (DexFerrum) removal by hemodialysis: an <it>in-vitro </it>study
by: Grabe Darren W, et al.
Published: (2004-01-01)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
by: Carlos P. Vio, et al.
Published: (2020-06-01)

The Difference Of Effectiveness way to Consume Iron tablets toward haemoglobin level changes to pregnant women in second trimester at the Sindang Barang community health center in 2017
by: Triswanti, et al.
Published: (2020-04-01)

Iron Intake and Hemoglobin Levels in Stunting in Adolescent
by: Addistyane Puristasari, et al.
Published: (2016-06-01)

Some factors concerned in the technique of measuring the availability of iron for hemoglobin formation
by: Joseph, Michael H., 1912-
Published: (1937)

Gambaran Kadar Hemoglobin pada Remaja Putri yang Mengkonsumsi Tablet Tambah Darah (FE)
by: Deby Illahi
Published: (2015-04-01)

Investigation of <i>Chlorella pyrenoidosa</i> Protein as a Source of Novel Angiotensin I-Converting Enzyme (ACE) and Dipeptidyl Peptidase-IV (DPP-IV) Inhibitory Peptides
by: Yuchen Li, et al.
Published: (2021-05-01)

Effectivity of Erythropoietin Alpha Compared to Erythropoietin Beta in Patients with Chronic Kidney Disease-Anemia on Hemodialysis
by: Anak Agung Ngurah Putra Riana Prasetya, et al.
Published: (2021-01-01)

PHARMACO-ECONOMICBENEFITS OF CORRECTION OF ANEMIA WITH CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR:HEMODIALYSIS VSHEMODIAFILTRATION
by: V. Novakivskyy
Published: (2017-03-01)